Fellows of the Pediatric Pharmacy Association (FPPA)

Purposes

The Fellows of the Pediatric Pharmacy Association (FPPA) Recognition Program serves the following purposes:

  1. to recognize excellence in pediatric pharmacy practice, and;
  2. to grant recognition and to promote public awareness of pharmacists who have distinguished themselves in pediatric pharmacy practice.

 

Authority

The FPPA Recognition Program shall be conducted under the general authority of the PPAG Board of Directors. The Board shall approve all regulations pertaining to the operation of the Recognition Program.

Governance

FPPA Recognition Committee: Function and Responsibilities

The program shall be administered by the FPPA Recognition Committee, which shall be appointed by the Board of Directors, and shall have the following specific responsibilities, with respect to the FPPA Program:

  1. to review and approve recognition eligibility criteria and, in general, to provide quality assurance for the program;
  2. to approve or not approve candidates for recognition as Fellows.
  3. to recommend to the Board of Directors any future changes in these Guidelines.


General Criteria for Recognition

The following is a list of general criteria for recognition as a Fellow. Acceptance is not guaranteed. The purpose of the criteria is to establish minimum requirements for acceptance to the Fellows recognition program. The FPPA Selection Committee evaluates each candidate based on the Criteria for Recognition. Current members of the Board of Directors are ineligible for consideration. Meeting minimum requirements does not guarantee acceptance as a Fellow.

Candidate must distinguish themselves in the profession and demonstrate sustained practice excellence and professionalism in pediatric pharmacy practice. (5 points)

Interpretation

The term “candidate”, for purposes of this program, includes pharmacists who have been in practice for a minimum of 10 years (post specialty residency training), and are current members of PPA for five (5) years at the time of nomination.

In fulfilling this criterion, it is expected that the level of demonstrated practice will reflect a commitment to practice excellence throughout his or her career. The candidate must provide sufficient documentation that a level of excellence has been achieved through sustained practice. For example, development, implementation, or enhancement of systems or programs (within the candidate's current or a previous practice site) that resulted in an improved level of practice. Particular emphasis shall be placed on innovation, creativity, and conceptualization of new or improved practice methods. Since it is recognized that these factors are not the exclusive basis upon which to determine practice excellence, other evidence submitted by the candidate that addresses this criterion will be considered.

Each candidate must assure that at least three colleagues (practitioners, administrators, or academicians) can attest to the applicant’s professionalism and contributions as a pediatric practitioner

Candidate shall have contributed to the total body of knowledge in pediatric pharmacy practice. (5 points)

Interpretation

The following may be submitted as evidence that the candidate has a record of contributing to the total body of knowledge in pharmacy practice.

  1. publication of scientific or professional papers on relevant topics of pharmacy and/or drug therapy in refereed journals (senior author or coauthor is acceptable); and/or publication of a textbook or a chapter(s) in a textbook(s) on some aspect of pharmacy and/or drug therapy; and/or
  2. presentations at professional meetings; and/or
  3. production or publication of educational aids on some aspect of pharmacy.

 

Candidate must be involved in and committed to educating practitioners in pediatric pharmacy practice and/or pharmacotherapy. (5 points)

Interpretation

Each candidate must be actively involved in educational programs. For example: a) making presentations to pediatric practitioners on topics that pertain to pediatric pharmacy practice; b) providing guidance to colleagues in practice; c) precepting residents; d) mentoring staff; e) training technicians; f) conducting clerkship/rotations; g) educating students; and/or, h) educating the public.

Candidate must demonstrate active involvement and leadership in professional activities, especially within the Pediatric Pharmacy Advocacy Group. (5 points)

Interpretation

Candidate must support the profession as evidenced by a record of consistent and active involvement and leadership in professional activities, such as membership and participation in PPAG. Some examples of activities in which a candidate may have participated are as follows:

  1. served as an elected officer of a national, state, regional, or local pharmacy organization;
  2. served as member of a pharmacy association policy recommending body;
  3. served as a member of a commission, committee, task force, or ad hoc group established by a national, state, regional or local pharmacy association;
  4. served as a reviewer, editorial board member, or editor for a national, professional refereed journal; and/or
  5. served as a reviewer of papers submitted for presentation at national pharmacy meetings.

 

Recognition of Exemplary leadership service to PPA. (up to 3 extra points)

​In addition to the general assessment of professional service, Fellow candidates can receive points rewarding exemplary service to PPA (national organization), specifically.

  1. ​Elected Officer of PPA (President, Secretary, Treasurer): 1 point
  2. More than one full term as Officer of PPA: 1 point
  3. ​Committee Chair: 0.5 points
  4. ​More than one successful term as chair: 0.5 points

 

FPPAG Recognition Application Evaluation and Designation of FPPA Status
 

  1. The FPPAG Recognition Committee membership includes current Fellows and is chaired by a current Fellow appointed by the PPAG President.
  2. ​The FPPAG Recognition Committee members individually evaluate each criteria for each applicant (each criteria is evaluated on a 5-point scale).
  3. Scores are averaged. Applicants must obtain a minimum average score of 18 points (out of 20) in order to be considered for FPPAG status. However, a score of 18 does not automatically designate a candidate as Fellow.  
  4. A candidate achieving recognition shall be designated a "Fellow of the Pediatric Pharmacy Advocacy Group" (FPPAG).
  5. Candidates achieving FPPAG status shall be recognized at a ceremony, conducted on their behalf, during the PPAG Annual Meeting.


Application Process

  1. Members of the PPAG Board of Directors or FPPA Recognition Committee are not eligible to apply during their term of office.
  2. Those interested in becoming a candidate must fill-out an online application form.
    1. All requests for applications submitted to PPAG will remain confidential. Materials submitted in support of a candidate's bid for recognition status shall not be received by anyone other than the members of the FPPA Recognition Committee, or others involved in the review process.
    2. ​Applications must be received by October 1 each year. 
  3. Candidates are required to solicit three (3) recommendations from colleagues who can support and attest to the candidate’s qualification as a Fellow of PPAG. Candidates will submit the names and email addresses of their references within the online application form, who will then receive an email inviting them to submit a letter or support. To this end, a colleague writing on his or her behalf must not focus on one accomplishment only but, rather, must personally assess the extent to which the applicant's overall contributions have made a positive impact on pediatric pharmacy practice. If a letter is submitted in lieu of the online form, it must address all areas contained in the on-line form.
    1. ​​Recommendation Forms/Letters must be received by the application deadline (October 1).
  4. Completed applications, including all supporting materials that address the specific criteria outlined for recognition status, can be submitted throughout the year. However, applications must be submitted on or before October 1 to be considered for the next calendar year. Only information contained in the application will be considered. The candidate has the burden of establishing that the criteria have been met. An application may be amended, expanded, or supplemented at any time until it is submitted to the FPPA Recognition Committee; thereafter, no changes can be made.
  5. Acknowledgement of receipt of the application shall be sent to the candidate.
  6. ​The Chair of the FPPA Recognition Committee will start his/her term in December of each year.
  7. The Executive Director of PPA will submit completed files on all candidates to the FPPA Recognition Committee in November of each year.
  8. The FPPA Recognition Committee will render its decision based only on the application materials and the criteria for recognition. Any member of the FPPA Recognition Committee who feels that he/she cannot be objective in review and voting on an application should excuse him/herself from the discussion and voting on the applicant. In this case, if a tie vote occurs the decision will be referred to the Board. The PPA Board of Directors and/or the FPPA Nominations Committee can recommend a candidate without a formal nomination.
  9. The FPPA Recognition Committee shall meet in October each year unless there are no candidates and no other business.
  10. ​FPPA Recognition Committee will provide FPPA recommendations to the Board of Directors during their November business meeting. 
  11. The candidate will be notified in writing, of the FPPA Recognition Committee decision following approval by the PPA Board of Directors no later than December each year.
  12. Successful candidates will be recognized at a special ceremony conducted on their behalf.

 

Approved by the PPA Board of Directors on October 1, 2008. Revised August 2010, July 2016, June 2018

List of Current Fellows

2009 Inductees

1. Marcia Buck, PharmD, FPPA
2.
James Dice, PharmD, FPPA
3.
Helen Fiechtner, PharmD, FPPA
4.
Kay Kyllonen, PharmD, FPPA

2010 Inductees 

5. Richard Helms, PharmD, FPPA
6.
Robert Kuhn, PharmD, FPPA
7.
Robert Poole, PharmD FPPA

2011 Inductees

8. Peter Gal, PharmD, FPPA
9.
Kathleen Gura, PharmD, FPPA
10.
Elizabeth Farrington, PharmD, FPPA
11.
Donna Kraus, PharmD, FPPA
12.
Anne Lesko, PharmD, FPPA
13.
Sherry Luedtke, PharmD, FPPA

2012 Inductees

14. Tracy Hagemann, PharmD, FPPA
15.
Kristin Klein, PharmD, FPPA

2013 Inductees

16. Kimberley Benner, PharmD, FPPA
17. Michael Christensen, PharmD, FPPA
18. Carlton Lee, PharmD, FPPA
19. Stephanie Phelps, PharmD, FPPA
20. Cathy Poon, PharmD, FPPA

2014 Inductees

21. Sandra Benavides, PharmD, FPPA
22. Katherine H. Chessman, PharmD, FPPA
23. Milap Nahata, PharmD, FPPA
24. Timothy Todd, PharmD, FPPA

2015 Inductees

25. Michelle Condren, PharmD, FPPA
26. Lea Eiland, PharmD, FASHP, FPPA

2016 Inductees

27. Michael Chicella, PharmD, FPPA
28.
David Hoff, PharmD, FPPA
29.
Peter Johnson, PharmD, FPPA
30.
Chad Knoderer, PharmD, FPPA
31.
Shannon Manzi, PharmD, FPPA

2017 Inductees

32. Edress Darsey, PharmD, FPPA
​33. William Maish, PharmD, FPPA (posthumously)
​34. Kalen Manasco, PharmD, FPPA

2018 Inductees

35. Jared Cash, PharmD, FPPA
​36. David Knoppert, FPPA
​37. Jamie Miller, PharmD, FPPA
​38. Kathy Pham, PharmD, FPPA
​39. Hanna Phan, PharmD, FPPA

2019 Inductees

40. Leslie Briars, PharmD, FPPA
41. Gilbert Burckart, PharmD, FPPA
42. Jeffrey Cies, PharmD, FPPA
43. Lisa Lubsch, PharmD, FPPA
44. Sarah Lucas, PharmD, FPPA
45. Rachel Meyers, PharmD, FPPA
46. Kimberly Novak, PharmD, FPPA
47. Mary Worthington, PharmD, FPPA